[1]
N. Chen, “Plasma cfDNA as a potential treatment monitoring and prognostic index in patients withnon-small cell lung cancer”, Cell Mol Biol (Noisy-le-grand), vol. 66, no. 5, pp. 208–213, Jul. 2020.